Results 161 to 170 of about 139,000 (340)

Gastrectomy for Peptic Ulcer [PDF]

, 1947
Magdy El-din, John W Warrick
openalex   +1 more source

The Relationship Between Quality of Discharge Teaching and Oral Nutritional Supplementation Adherence in Postoperative Patients With Gastric Cancer: A Chain Mediated Role of Readiness for Hospital Discharge and Medication Beliefs

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim We aimed to elucidate the underlying mechanisms influencing Oral nutritional supplementation (ONS) adherence in postoperative patients with gastric cancer (GC) by developing a structural equation model. Background ONS represents a cost‐effective nutritional intervention for postoperative patients with GC, with its efficacy largely ...
Fang Shen, Xiaoxue Chen, Hong Yu, Fang Xiao, Xiuhong Yuan, Jia Li   +5 more
wiley   +1 more source

Hypoglycaemia Following Partial Gastrectomy [PDF]

, 1947
R. D. Lawrence
openalex   +1 more source

GASTRECTOMY

Annals of Surgery, 1932
Graham As, Mann Fc
openaire   +3 more sources

Cholecystokinin: Clinical aspects of the new biology

Journal of Internal Medicine, EarlyView.
Abstract Cholecystokinin (CCK) is a classic gut hormone that has been known for almost a century to regulate gallbladder emptying, pancreatic enzyme secretion, and gastrointestinal motor activity. In 1968, the CCK structure was identified by Viktor Mutt and Erik Jorpes from porcine gut extracts as a peptide of 33 amino acid residues.
Jens F. Rehfeld
wiley   +1 more source

TOTAL GASTRECTOMY BY THE TRANSTHORACIC APPROACH

, 1943
Richard H. Sweet
openalex   +2 more sources

Oxytocin mRNA is expressed throughout the small intestine in individuals with and without type 2 diabetes, and circulating neurophysin I declines after Roux‐en‐Y gastric bypass surgery

Diabetes, Obesity and Metabolism, EarlyView.
Ida M. Gether, Hannah Gilliam‐Vigh, Vivian Kliim‐Hansen, Bolette Hartmann, Jens J. Holst, Asger B. Lund, Lærke S. Gasbjerg, Filip K. Knop   +7 more
wiley   +1 more source

Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment

Neurogastroenterology &Motility, EarlyView.
DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier, Janita Halminen, Malin Björck, Gudrún Höskuldsdóttir, Karin Mossberg, My Engström, Björn Eliasson, Ville Wallenius, Lars Fändriks, Jan Tack, Hans Törnblom, Magnus Simrén   +11 more
wiley   +1 more source

Gastrectomy-induced alterations in gut microbiota linked to changes in oral and gastric microbiota. [PDF]

Front Microbiol
Komori E, Kato-Kogoe N, Imai Y, Sakaguchi S, Taniguchi K, Omori M, Ohmichi M, Hamada W, Nakamura S, Nakano T, Lee SW, Ueno T.   +11 more
europepmc   +1 more source

Histidine‐Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review

Obesity Reviews, EarlyView.
ABSTRACT Background Histidine‐containing dipeptides (HCDs) have been reported to have anti‐inflammatory and antidiabetic properties. Yet, no previous reviews have examined the impact of HCDs on Type 2 diabetes (T2D) risk factors (e.g., obesity) and progression (e.g., microvascular and macrovascular complications).
Saeede Saadati, Robel Hussen Kabthymer, Giancarlo Aldini, Thilini R. Thrimawithana, Julie E. Stevens, Kathy Ngyuen, Arshad Majid, Simon M. Bell, Jack Feehan, Aya Mousa, Barbora de Courten   +10 more
wiley   +1 more source